MedPath

A randomized clinical trial on the effect of combining modified Gualouxiebaiguizhi Decoction with Enhanced External Counterpulsation to treat coronary slow flow

Phase 1
Conditions
coronary slow flow
Registration Number
ITMCTR2200005991
Lead Sponsor
Beijing University of Chinese Medicine Shenzhen Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

age between 18-75, no gender restriction; meet with the criteria of CSF; meet with the criteria of TCM heart yang deficiency with phlegm and blood stasis syndrome

Exclusion Criteria

patients with severe heart, lung, liver, kidney or brain disease;patients with acute infection or bleeding disorders; severe endocrine or electrolyte disorders; uncontrolled blood pressure; organ fibrosis; pregnant or breastfeeding women; patients with mental disorders or epidemic diseases; patients involved in another clinical trial.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SF-12;SAQ;indicators of blood stickiness;effectiveness rate of;TCM symptom score;ECG;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath